A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine. Horner C, Schurmann C, Auste A, Ebenig A, et al. Proc Natl Acad Sci U S A 2020 Nov 30. pii: 2014468117.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Horner C, Schurmann C, Auste A, Ebenig A, et al. A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine. Proc Natl Acad Sci U S A 2020 Nov 30. pii: 2014468117.
PMID: 33257540